The advancements, perspectives, and challenges in blood–brain-barrier (BBB)-crossing nanotechnology for effective brain tumor delivery and highly efficient brain cancer theranostics.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2019) studied this question.